TransMolecular, Inc.

TetraLogic Pharmaceuticals, a biopharmaceutical company developing drugs to treat cancer, has appointed Jonathan Lloyd Jones chief financial officer and vice-president of corporate development. From 2

In Vitro Diagnostics Mergers & Acquisitions /In Vitro Diagnostics BG Medicine Inc. Boston Scientific Corp. Boston Scientific Corp. has signed on to use newly public molecular diagnostics company

Eisai has signed licensing and technology deals with two bioventures, both of which are aimed at strengthening its R&D activities in oncology, which the Japanese firm has positioned as a strategic the

Topaz Pharmaceuticals has appointed Bob Radie president and chief executive officer. Dr Thomas Beck, who has been serving as interim CEO, will resume his role as chief medical officer. Mr Radie was mo